Judge Keeps BMS Securities Suit In Play

Law360, New York (August 20, 2008, 12:00 AM EDT) -- A federal judge has denied Bristol-Myers Squibb Co.'s motion to dismiss a securities class action that accuses BMS of duping shareholders and causing a stock drop when it failed to properly disclose a patent deal for a generic version of its blood-thinning drug Plavix.

Judge Paul A. Crotty in the U.S. District Court for the Southern District of New York handed down the order Tuesday, denying BMS and former executives Peter Dolan and Andrew Bodnar's motion to dismiss an amended complaint filed jointly by the Ontario...
To view the full article, register now.